A novel therapeutic target, GPR43; Where it stands in drug discovery

Archives of Pharmacal Research

Volumn 35, Issue 9, 2012, Pages 1505-1509

  Kim, Sunhong ^a,b   Kim, You Me ^c   Kwak, Young Shin ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; FATTY ACID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 40; G PROTEIN COUPLED RECEPTOR 41; G PROTEIN COUPLED RECEPTOR 42; G PROTEIN COUPLED RECEPTOR 43; G PROTEIN COUPLED RECEPTOR 43 AGONIST; GLPG 0974; PEPTIDE YY; PROGLUCAGON; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ARTICLE; DRUG TARGETING; ENTERITIS; HUMAN; INFLAMMATORY DISEASE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY;

ADIPOGENESIS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG DISCOVERY; DRUGS, INVESTIGATIONAL; HUMANS; LIGANDS; LIPOLYSIS; METABOLIC SYNDROME X; MOLECULAR TARGETED THERAPY; OVERWEIGHT; RECEPTORS, CELL SURFACE;

EID: 84872102587     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-0900-6     Document Type: Article

References (42)

1. Bernard, J., Hartiel, A. F., Brantis, C., Hoveyda, H., and Fraser, G., Identification of a small-molecule GPR43 agonist that Increases glucose uptake and inhibits lipolysis in adipocytes. American Diabetes Association Annual Meeting, New Orleans, LA, USA, 69, Abs1362p (2009).
2. Bjursell, M., Admyre, T., Goransson, M., Marley, A. E., Smith, D. M., Oscarsson, J., and Bohlooly, Y. M., Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab., 300, E211-E220 (2011).
3. Bockaert, J. and Pin, J. P., Molecular tinkering of G proteincoupled receptors: an evolutionary success. EMBO J., 18, 1723-1729 (1999).
4. Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., Pike, N. B., Strum, J. C., Steplewski, K. M., Murdock, P. R., Holder, J. C., Marshall, F. H., Szekeres, P. G., Wilson, S., Ignar, D. M., Foord, S. M., Wise, A., and Dowell, S. J., The Orphan G proteincoupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem., 278, 11312-11319 (2003).
5. Campbell, P. J., Carlson, M. G., and Nurjhan, N., Fat metabolism in human obesity. Am. J. Physiol., 266, E600- E605 (1994).
6. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., and Lionetti, P., Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U. S. A., 107, 14691-14696 (2010).
7. Euroscreen, Compound, Pharmaceutical Composition and Methods for Use in Treating Metabolic Disorders. Wipo, WO 2010/066682 A1 (2010).
8. Euroscreen, Novel Compounds, Method for Use Them and Pharmaceutical Composition Containing Them. WIPO, WO 2011/151436 A2 (2011a).
9. Euroscreen, Pyrrolidine or Thiazolidine Carboxylic Acid Derivatives, Pharmaceutical Composition and Methods for Use in Treating Metabolic Disorders as Agonists of Gprotein Coupled Receptor 43 (GPR43). WIPO, WO2011/073376A1 (2011b).
10. Fredriksson, R., Lagerstrom, M. C., Lundin, L. G., and Schioth, H. B., The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol., 63, 1256-1272 (2003).
11. Ge, H., Li, X., Weiszmann, J., Wang, P., Baribault, H., Chen, J. L., Tian, H., and Li, Y., Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology, 149, 4519-4526 (2008).
12. Haber, E. P., Ximenes, H. M., Procopio, J., Carvalho, C. R., Curi, R., and Carpinelli, A. R., Pleiotropic effects of fatty acids on pancreatic beta-cells. J. Cell Physiol., 194, 1-12 (2003).
13. Hatanaka, H., Tsukui, M., Takada, S., Kurashina, K., Choi, Y. L., Soda, M., Yamashita, Y., Haruta, H., Hamada, T., Ueno, T., Tamada, K., Hosoya, Y., Sata, N., Yasuda, Y., Nagai, H., Sugano, K., and Mano, H., Identification of transforming activity of free fatty acid receptor 2 by retroviral expression screening. Cancer Sci., 101, 54-59 (2010).
14. Hong, Y. H., Nishimura, Y., Hishikawa, D., Tsuzuki, H., Miyahara, H., Gotoh, C., Choi, K. C., Feng, D. D., Chen, C., Lee, H. G., Katoh, K., Roh, S. G., and Sasaki, S., Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology, 146, 5092-5099 (2005).
15. IDF, The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation, Brussels, Belgium, (2006).
16. Insel, P. A., Tang, C. M., Hahntow, I., and Michel, M. C., Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets. Biochim. Biophys. Acta, 1768, 994-1005 (2007).
17. Karaki, S., Mitsui, R., Hayashi, H., Kato, I., Sugiya, H., Iwanaga, T., Furness, J. B., and Kuwahara, A., Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res., 324, 353-360 (2006).
18. Karaki, S., Tazoe, H., Hayashi, H., Kashiwabara, H., Tooyama, K., Suzuki, Y., and Kuwahara, A., Expression of the shortchain fatty acid receptor, GPR43, in the human colon. J. Mol. Histol., 39, 135-142 (2008).
19. Kolakowski, L. F., Jr., GCRDb: a G-protein-coupled receptor database. Recept. Channels, 2, 1-7 (1994).
20. Lagerstrom, M. C. and Schioth, H. B., Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov., 7, 339-357 (2008).
21. Le Poul, E., Loison, C., Struyf, S., Springael, J. Y., Lannoy, V., Decobecq, M. E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., Parmentier, M., and Detheux, M., Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem., 278, 25481-25489 (2003).
22. Lee, T., Schwandner, R., Swaminath, G., Weiszmann, J., Cardozo, M., Greenberg, J., Jaeckel, P., Ge, H., Wang, Y., Jiao, X., Liu, J., Kayser, F., Tian, H., and Li, Y., Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Mol. Pharmacol., 74, 1599-1609 (2008).
23. Leonard, J. N. A. H., Y. GPR43 and Modulators Thereof for the Treatment of Metabolic-Related Disorders. Arena Pharmaceuticals, US 2010/0093604 A1 (2010).
24. Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., Xavier, R. J., Teixeira, M. M., and Mackay, C. R., Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature, 461, 1282- 1286 (2009).
25. Mcneil, N. I., The contribution of the large intestine to energy supplies in man. Am. J. Clin. Nutr., 39, 338-342 (1984).
26. Nilsson, N. E., Kotarsky, K., Owman, C., and Olde, B., Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem. Biophys. Res. Commun., 303, 1047-1052 (2003).
27. Reaven, G. M., Hollenbeck, C., Jeng, C. Y., Wu, M. S., and Chen, Y. D., Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes, 37, 1020-1024 (1988).
28. Sawzdargo, M., George, S. R., Nguyen, T., Xu, S., Kolakowski, L. F., and O'dowd, B. F., A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1. Biochem. Biophys. Res. Commun., 239, 543-547 (1997).
29. Sina, C., Gavrilova, O., Forster, M., Till, A., Derer, S., Hildebrand, F., Raabe, B., Chalaris, A., Scheller, J., Rehmann, A., Franke, A., Ott, S., Hasler, R., Nikolaus, S., Folsch, U. R., Rose-John, S., Jiang, H. P., Li, J., Schreiber, S., and Rosenstiel, P., G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J. Immunol., 183, 7514-7522 (2009).
30. Swaminath, G., Jaeckel, P., Guo, Q., Cardozo, M., Weiszmann, J., Lindberg, R., Wang, Y., Schwandner, R., and Li, Y., Mutational analysis of G-protein coupled receptor-FFA2. Biochem. Biophys. Res. Commun., 405, 122-127 (2011).
31. Takeda, S., Kadowaki, S., Haga, T., Takaesu, H., and Mitaku, S., Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett., 520, 97-101 (2002).
32. Tang, Y., Chen, Y., Jiang, H., Robbins, G. T., and Nie, D., G-protein- coupled receptor for short-chain fatty acids suppresses colon cancer. Int. J. Cancer, 128, 847-856 (2011).
33. Tazoe, H., Otomo, Y., Kaji, I., Tanaka, R., Karaki, S. I., and Kuwahara, A., Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J. Physiol. Pharmacol., 59 Suppl 2, 251-262 (2008).
34. Tiwari, A., GPR43: an emerging target for the potential treatment of type 2 diabetes, obesity and insulin resistance. Curr. Opin. Investig. Drugs, 11, 385-393 (2010).
35. Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., and Gribble, F. M., Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes, 61, 364-371 (2012).
36. Uronis, J. M., Muhlbauer, M., Herfarth, H. H., Rubinas, T. C., Jones, G. S., and Jobin, C., Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One, 4, e6026 (2009).
37. Vassilatis, D. K., Hohmann, J. G., Zeng, H., Li, F., Ranchalis, J. E., Mortrud, M. T., Brown, A., Rodriguez, S. S., Weller, J. R., Wright, A. C., Bergmann, J. E., and Gaitanaris, G. A., The G protein-coupled receptor repertoires of human and mouse. Proc. Natl. Acad. Sci. U. S. A., 100, 4903-4908 (2003).
38. Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., Sitaraman, S. V., Knight, R., Ley, R. E., and Gewirtz, A. T., Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science, 328, 228-231 (2010).
39. Vinolo, M. A., Ferguson, G. J., Kulkarni, S., Damoulakis, G., Anderson, K., Bohlooly, Y. M., Stephens, L., Hawkins, P. T., and Curi, R., SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS One, 6, e21205 (2011a).
40. Vinolo, M. A., Rodrigues, H. G., Nachbar, R. T., and Curi, R., Regulation of inflammation by short chain fatty acids. Nutrients, 3, 858-876 (2011b).
41. Wang, Y., Jiao, X., Kayser, F., Liu, J., Wang, Z., Wanska, M., Greenberg, J., Weiszmann, J., Ge, H., Tian, H., Wong, S., Schwandner, R., Lee, T., and Li, Y., The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators. Bioorg. Med. Chem. Lett., 20, 493- 498 (2010).
42. Yonezawa, T., Kobayashi, Y., and Obara, Y., Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. Cell Signal., 19, 185-193 (2007).